Volume 10, Number 12—December 2004
Research
Crimean-Congo Hemorrhagic Fever, Mauritania
Pierre Nabeth*
, Dah Ould Cheikh†, Baidy Lo‡, Ousmane Faye*, Idoumou Ould Mohamed Vall†, Mbayame Niang*, Bocar Wague†, Djibril Diop‡, Mawlouth Diallo*, Boubacar Diallo§, Ousmane Madiagne Diop*, and François Simon*
, Dah Ould Cheikh†, Baidy Lo‡, Ousmane Faye*, Idoumou Ould Mohamed Vall†, Mbayame Niang*, Bocar Wague†, Djibril Diop‡, Mawlouth Diallo*, Boubacar Diallo§, Ousmane Madiagne Diop*, and François Simon*
Table 1
Distribution of Crimean-Congo hemorrhagic fever cases that were confirmed by serologic test, Mauritania, February–August 2003
| Laboratory testa | No. positive (%)b |
|---|---|
| ELISA-IgM | 22 (64.7) |
| RT-PCR | 1 (2.9) |
| Isolation | 2 (5.9) |
| ELISA-IgM + RT-PCR | 6 (17.6) |
| ELISA-IgM + RT-PCR + isolation | 3 (8.8) |
| Total | 34 (100.0) |
aELISA, enzyme-linked immunosorbent assay; RT-PCR, reverse transcription–polymerase chain reaction; Ig, immunoglobulin.
bAn additional 4 persons met the criteria for having a probable case but died before sampling, so their cases could not be confirmed with serologic tests; according to the case definition, these persons were considered case-patients, which brings the total number of cases to 38.
Page created: June 16, 2011
Page updated: June 16, 2011
Page reviewed: June 16, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.